Aslan Pharmaceuticals Probability of Future Stock Price Finishing Over 3.58
| ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan |
Aslan Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aslan Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aslan Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aslan Pharmaceuticals is not yet fully synchronised with the market data | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Aslan Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aslan Stock often depends not only on the future outlook of the current and potential Aslan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aslan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.4 M | |
| Cash And Short Term Investments | 21.3 M |
Aslan Pharmaceuticals Technical Analysis
Aslan Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Aslan Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aslan Pharmaceuticals. In general, you should focus on analyzing Aslan Stock price patterns and their correlations with different microeconomic environments and drivers.
Aslan Pharmaceuticals Predictive Forecast Models
Aslan Pharmaceuticals' time-series forecasting models is one of many Aslan Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aslan Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Aslan Pharmaceuticals
Checking the ongoing alerts about Aslan Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aslan Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aslan Pharmaceuticals is not yet fully synchronised with the market data | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |